Avidity Biosciences, Inc.
RNA · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$174 | -$157 | -$116 | -$102 |
| Dep. & Amort. | $1 | -$8 | $1 | $1 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $19 | $18 | $18 | $14 |
| Change in WC | -$1 | -$58 | -$23 | -$6 |
| Other Non-Cash | -$1 | $6 | -$4 | -$6 |
| Operating Cash Flow | -$156 | -$200 | -$125 | -$100 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$1 | -$3 | -$4 | -$4 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$854 | -$74 | -$169 | -$297 |
| Inv. Sales/Matur. | $270 | $263 | $330 | $237 |
| Other Inv. Act. | -$3 | $0 | $0 | $0 |
| Investing Cash Flow | -$588 | $185 | $157 | -$64 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $837 | $4 | $2 | -$142 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $13 | $0 | $0 | $156 |
| Financing Cash Flow | $850 | $4 | $2 | $14 |
| Forex Effect | -$0 | $0 | $0 | $0 |
| Net Chg. in Cash | $106 | -$10 | $34 | -$150 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $247 | $257 | $220 | $373 |
| End Cash | $353 | $247 | $254 | $223 |
| Free Cash Flow | -$160 | -$203 | -$129 | -$104 |